13F
中

CTNM CONTINEUM THERAPEUTICS INC-A

2026Q1 · CUSIP 21217B100 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
89
Δ holders QoQ
+9
Breadth percentile
Top 31%
Whale holders
41
Δ whales
+8
Inst. holding value
$399M
New positions
22
Closed positions
13
Price momentum (1Q)
-12.5%
Put / Call
0/1

Breadth history (34 quarters)

2024Q3: Δ+2 · h=52 2024Q4: Δ+11 · h=63 2025Q1: Δ+1 · h=64 2025Q2: Δ+8 · h=72 2025Q3: Δ-10 · h=62 2025Q4: Δ+18 · h=80 2026Q1: Δ+9 · h=89 2024Q3: holders=52 2024Q4: holders=63 2025Q1: holders=64 2025Q2: holders=72 2025Q3: holders=62 2025Q4: holders=80 2026Q1: holders=89 -18 -9 +0 +9 +18 467094 24Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: -1
Call holders
1
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.94
EPS YoY
-358.7%
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-06-30: EPS -0.39 2024-09-30: EPS -0.40 2025-03-31: EPS -0.62 2025-06-30: EPS -0.62 2025-09-30: EPS -0.45 2025-12-31: EPS -0.48 2026-03-31: EPS -0.39 -0.68 -0.34 0.00 2023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)